Allworth Financial’s Cellectis CLLS Stock Holding History

Allworth Financial’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58K	Sell	500 -154	-24%	-$590	﹤0.01%	4422
2025 Q4	$3.17K	Buy	654 +154	+31%	+$644	﹤0.01%	3949
2025 Q3	$1.43K	Hold	500	–	–	﹤0.01%	4149
2025 Q2	$763	Sell	500 -1,100	-69%	-$1.59K	﹤0.01%	4025
2025 Q1	$2.42K	Buy	1,600 +1,100	+220%	+$1.63K	﹤0.01%	3129
2024 Q4	$765	Hold	500	–	–	﹤0.01%	3488
2024 Q3	$1.06K	Hold	500	–	–	﹤0.01%	3196
2024 Q2	$1.01K	Hold	500	–	–	﹤0.01%	3153
2024 Q1	$1.32K	Hold	500	–	–	﹤0.01%	2983
2023 Q4	$1.54K	Buy	+500	New	+$1.19K	﹤0.01%	2791
2021 Q1	–	Sell	-7	Closed	–	–	1498
2020 Q4	$0	Buy	+7	New	+$157	﹤0.01%	1349

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Allworth Financial's CLLS Position: Q1 2026 in Review

Allworth Financial reduced its Cellectis (CLLS) stake by 24% in Q1 2026, selling an estimated $590 and leaving 500 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #4422.

Allworth Financial first reported a position in CLLS in Q4 2020 and has held it in 11 quarters since. The position peaked at $3.17K in Q4 2025. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

Allworth Financial held 500 shares of Cellectis worth $1.58K as of Q1 2026.
Allworth Financial sold 154 Cellectis shares in Q1 2026, an estimated $590.
Cellectis made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4422 holding.
Allworth Financial first reported a position in Cellectis in Q4 2020 and has held it in 11 quarters since.
Allworth Financial's Cellectis position peaked at $3.17K in Q4 2025.
32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.